Production of a lentiviral vector, CX170 from vector biomed

Active Purchase Order Awarded Last action

Contract number
75N92024P00292
Awardee
Awarding agency
Obligated
$611,500

Award facts

Contract value 100% obligated
$611,500.00 Current and potential, with all options
Completion date 72% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Gaithersburg, MD 20878, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The National Heart Lung and Blood Institute (NHLBI) awarded a $611,500.00 firm fixed-price purchase order contract to Vector Biomed Inc. for the production of a lentiviral vector, CX170. This contract, which does not have a set-aside designation, has a completion date of September 2, 2027. The place of performance is in NO POTOMAC, MD 20878, USA.

Quick answers

Who was awarded contract 75N92024P00292?

75N92024P00292 was awarded to Vector Biomed Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 3, 2024.

How much is contract 75N92024P00292 worth?

The government has obligated $611,500 on 75N92024P00292.

Was contract 75N92024P00292 competed?

The extent of competition for 75N92024P00292 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award